Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01096316 · ClinicalTrials.gov registry record · NA
Depression Attention for Women Now (The DAWN Study)
A NA study of Depressive Disorder, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 205
- Enrollment target
- 2
- Study locations
NCT01096316: Completed NA study of Depressive Disorder, sponsored by University of Washington.
NCT01096316 is a NA study of Depressive Disorder that has completed, run by University of Washington. The registered enrollment target is 205 participants, below the 327-participant average among 47 other Depressive Disorder trials with a reported enrollment target (37% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01096316, a NA study of Depressive Disorder, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 205 participants
- Enrollment target
- 2
- Study locations
Study Summary
Major depressive disorder (MDD) is a common disabling illness that disproportionately affects women, with prevalence rates two times those of men. In addition to suffering, MDD has been shown to have a marked effect on social and vocational functioning, with increased disability, lost productivity, and excess mortality. Women with MDD have an increased prevalence of comorbid anxiety disorders and medical conditions. Our model of care utilizes a social worker as a depression care manager (DCM) to support both patients and physicians in optimizing care in the OB-GYN clinical setting. This intervention will be compared to usual care for depression.
Primary Outcome
Impact of the intervention on depression treatment outcomes, including change in depressive symptoms and treatment response. In particular, the depression scale from the Hopkins Symptom Checklist 20 (SCL-20) was used to assess depression severity at the assessments. The SCL-20 ranges from 0 (no depression) to 4 (severe depression),
Conditions Studied
Interventions
- BEHAVIORAL Depression Care Management
Study Locations (2)
Washington
- Women's Clinic at Harborview Medical Center - Seattle
- Women's Health Care Center at University of Washington Medical Center (Roosevelt Clinic) - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2009-11 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT01096316 record still lists
NCT01096316 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 327-participant average among 47 other Depressive Disorder trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Depression Care Management is the first listed.
NCT01096316 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01096316 about?
NCT01096316 is a clinical study titled "Depression Attention for Women Now (The DAWN Study)". Major depressive disorder (MDD) is a common disabling illness that disproportionately affects women, with prevalence rates two times those of men. In addition to suffering, MDD has been shown to have a marked effect on social and vocational functioning, with increased disability, lost productivity, ...
What is the current status of trial NCT01096316?
This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2009-11. Estimated completion is 2015-05.
What conditions does trial NCT01096316 study?
This clinical trial studies the following conditions: Depressive Disorder.
What interventions are being tested in trial NCT01096316?
The interventions under investigation include: Depression Care Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT01096316?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01096316 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01096316's enrollment target sits among peer trials
205 12th of 47 higher than 36 of 47 other Depressive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
-
Measurement-Based Care (MBC) Implementation, Effectiveness, and Mechanisms of Change
RECRUITING · NA
-
Research Evaluating Vagal Excitation AND Anatomical Links
RECRUITING · NA
-
Unified Protocol: Community Connections
RECRUITING · NA
-
Enhancing Brain And Mental Health Through Breathing Practice
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia